Pimonidazole labelling and response to fractionated irradiation of five human squamous cell carcinoma (hSCC) lines in nude mice: The need for a multivariate approach in biomarker studies
- 1 November 2006
- journal article
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 81 (2) , 122-129
- https://doi.org/10.1016/j.radonc.2006.08.010
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- A comparison of oral and intravenous pimonidazole in canine tumors using intravenous CCI-103F as a control hypoxia markerInternational Journal of Radiation Oncology*Biology*Physics, 2006
- Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center studyRadiotherapy and Oncology, 2005
- Decreased repopulation as well as increased reoxygenation contribute to the improvement in local control after targeting of the EGFR by C225 during fractionated irradiationRadiotherapy and Oncology, 2005
- Does heterogeneity of pimonidazole labelling correspond to the heterogeneity of radiation-response of FaDu human squamous cell carcinoma?Radiotherapy and Oncology, 2005
- Tumor Hypoxia Has Independent Predictor Impact Only in Patients With Node-Negative Cervix CancerJournal of Clinical Oncology, 2002
- Quantifying the position and steepness of radiation dose-response curvesInternational Journal of Radiation Biology, 1997
- Calibration of misonidazole labeling by simultaneous measurement of oxygen tension and labeling density in multicellular spheroidsInternational Journal of Cancer, 1995
- Bootstrap Methods for Standard Errors, Confidence Intervals, and Other Measures of Statistical AccuracyStatistical Science, 1986
- Dosimetric Precision Requirements in Radiation TherapyActa Radiologica: Oncology, 1984
- Evidence for acutely hypoxic cells in mouse tumours, and a possible mechanism of reoxygenationThe British Journal of Radiology, 1979